HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (15) , 4480-4483
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Exploding Field of the HCV Polymerase Non-Nucleoside Inhibitors: Summary of a First Generation CompoundsMini-Reviews in Medicinal Chemistry, 2008
- Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseBioorganic & Medicinal Chemistry Letters, 2008
- New developments in the discovery of agents to treat hepatitis C.Current Topics in Medicinal Chemistry, 2008
- Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee ModelAntimicrobial Agents and Chemotherapy, 2007
- Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivativesBioorganic & Medicinal Chemistry Letters, 2007
- Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 2006
- 3-(1,1-Dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, Potent Inhibitors of Hepatitis C Virus RNA-Dependent RNA PolymeraseJournal of Medicinal Chemistry, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005
- Unravelling hepatitis C virus replication from genome to functionNature, 2005
- A Convenient Synthesis of 2H-1,2,4-Benzothiadiazine 1,1-Dioxides from 2-Aminobenzenesulfonamide and Carboxylic Acids by using Polyphosphoric Acid Trimethylsilyl Ester as Condensing AgentSynthesis, 1983